Topic
Cancer Imaging Program
About: Cancer Imaging Program is a research topic. Over the lifetime, 5 publications have been published within this topic receiving 805 citations.
Papers
TL;DR: The workshop dealt with research trends and avenues for improving imaging and applications across the clinical spectrum of the disease and four main clinical challenges in prostate cancer treatment and management-diagnostic accuracy, risk stratification, initial staging, active surveillance, and focal therapy were discussed.
Abstract: OBJECTIVE. This article reviews a recent 2-day workshop on prostate cancer and imaging technology that was conducted by the Cancer Imaging Program of the National Cancer Institute. The workshop dea...
205 citations
TL;DR: The establishment of the CIP as a clinical program under a provincial cancer agency has enabled the development of an Imaging Community of Practice and allowed for work on provincial-wide initiatives that enable quality improvement of cancer imaging.
Abstract: 244 Background: The Cancer Imaging Program (CIP) at Cancer Care Ontario was established in 2009 to improve the quality of cancer imaging in Ontario. Methods: After initial selection of a Provincial...
2 citations
TL;DR: The work of Dr Mason and his colleagues has been supported by the National Cancer Institute, Cancer Prevention and Research Institute of Texas, Department of Defense breast and prostate cancer initiatives and various foundations.
Abstract: Ralph Mason speaks to Sarah Miller, Commissioning Editor. Dr Ralph Mason, an expert in prognostic radiology, currently serves as Director of the Cancer Imaging Program at UT Southwestern (TX, USA), putting his experience of over 20 years in cancer imaging, therapy and tumor pathophysiology to good use. He is also a Professor of radiology and a member of the Simmons Comprehensive Cancer Center. For many years, the work of Dr Mason and his colleagues has been supported by the National Cancer Institute, Cancer Prevention and Research Institute of Texas, Department of Defense breast and prostate cancer initiatives and various foundations. His primary research interest is prognostic radiology and his current work focuses on oxygen-sensitive MRI in various human cancers. In addition, Dr Mason is an expert in the development of novel 19F NMR reporter strategies. His ongoing projects concern the investigation of novel gene reporter molecules, novel vascular disrupting agents and novel drug efficacy and approaches...
University of Texas MD Anderson Cancer Center1, University of Chicago2, Emory University3, University of Pittsburgh4, New York University5, Case Western Reserve University6, Georgetown University Medical Center7, Stanford University8, Stony Brook University9, Hunter Holmes McGuire VA Medical Center10
TL;DR: These workshops linked clinical and scientific requirements of currently known phenotypic and genotypic cancer biology characteristics with imaging phenotypes that underpin genomics and clinical outcomes and generated a set of recommendations to NCI leadership and the research community that encourage and support development of the emerging radiogenomics research field.
Washington University in St. Louis1, Stanford University2, University of Texas MD Anderson Cancer Center3, University of Toronto4, University of Pennsylvania5, National Institutes of Health6, University of Washington7, University of Texas Southwestern Medical Center8, Mount Vernon Hospital9, Georgetown University10, St George's, University of London11, Johns Hopkins University12, Dartmouth College13, University of Mainz14
TL;DR: Recommendations are yielded on using hypoxia measurement to identify patients who would respond best to radiation therapy, which would improve treatment planning and represent a narrow focus, as hypoxIA measurement might also prove useful in drug development and in increasing the understanding of tumor biology.
Abstract: James L. Tatum, Cancer Imaging Program, Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI)Gary J. Kelloff, Cancer Imaging Program, Division of Cancer Treatment and D...
Related Topics (5)
Performance Metrics
| Year | Papers |
|---|---|
| 2014 | 2 |
| 2013 | 1 |
| 2009 | 1 |
| 2006 | 1 |